What Is It?

A new pathway to early heart failure detection.

The Vivio® System (Vivio) is the first and only non-invasive solution for definitively measuring LVEDP – the clinical hallmark of identifying elevated filling pressure and diagnosing heart failure. By aiding diagnosis in minutes and doing so in expanded care environments, mobile technologies like Vivio are significantly reducing barriers to care for those populations impacted by social determinants of health (SDoH).

Request a demo with a Ventric Health consultant or get to know how Vivio works here.

Vivio® Key Advantages

Ventric Health Vivio System hardware components including the EKG patch, arm cuff, and tablet interface for guided heart failure diagnosis.

FDA-cleared Class II medical device with over 30,000 real-world patients screened

3-minute non-invasive test right in your exam room

Accurately identifies elevated LVEDP – clinical hallmark of heart failure

Supports compliant diagnosis of heart failure in the primary care setting

Where traditional tools such as natriuretic peptides, echocardiography, or clinical scoring systems may lack sensitivity or require specialist involvement, Vivio delivers hospital-grade diagnostic clarity directly in the primary care environment.1

How It Works

A physics-based approach to cardiac assessment.

  • Vivio measures the relationships between pressure waves produced during cardiac preload and afterload, along with contractility, to estimate left ventricular end diastolic volume (LVEDV).
  • Using a physics-based model of the cardiovascular system — not AI or machine learning — Vivio computes whether left ventricular end diastolic pressure (LVEDP) is elevated (>18 mmHg).
Diagram for the left heart

Six steps to real-time results.

Here’s how clinicians perform an evaluative test in the clinic or home in under five minutes to aid in the diagnosis of heart failure.

Clinician signs in to access the Vivio application on tablet.

Enter pertinent patient information including existing chronic conditions like diabetes or kidney disease that prompted ordering a Vivio test.

Place the EKG patch and arm cuff on the patient and connect effortlessly via Bluetooth.

Start the Vivio test to begin gathering heart data non-invasively – this process will take only two to three minutes for full data capture.

Vivio analyzes the biometric and wave form data the patch and cuff collected in less than 60 seconds.

Receive test results in real time.

Following a positive test for elevated LVEDP, Vivio prompts to complete the KCCQ-12.

Employing KCCQ into the clinical workflow.

  • Vivio incorporates the Kansas City Cardiomyopathy Questionnaire (KCCQ) — the most widely used tool for evaluating health status in heart failure patients — directly into clinical workflows.
  • The KCCQ provides a standardized, validated history and assessment for all newly diagnosed heart failure patients, supporting consistent care across the system.
  • Together, Vivio test results and the KCCQ allow clinicians to assess current and longitudinal patient health status and help determine when specialty referral may be appropriate.
Tablet screen depicting the Kansas City Cardiomyopathy Questionnaire (KCCQ-12).

Fewer than Five Minutes

That’s all it takes for the Vivio System to deliver the insights clinicians need to act with confidence. And, it’s a non-invasive solution that patients prefer for heart failure diagnosis.

In this video, you’ll see a clinician administer a Vivio test in under three minutes.

Below, you’ll see what patients have said about their Vivio experience and perspectives from customers and industry experts.

Vivio has superior sensitivity and specificity to clinical indications of heart failure thanks to its unmatched ability to accurately identify elevated LVEDP – faster,  easier and more accurately than echocardiogram.

Who It Benefits

Changing heart failure diagnosis for everyone.

Heart failure is a challenge to diagnose early and a costly burden on healthcare systems. Vivio is shifting heart failure diagnosis to outpatient settings, leading to earlier detection, earlier treatment, better outcomes, improved patient-centric care and decreased costs.

For Patients

  • Decreased 30-Day and One-Year Mortality2,3

  • Decreased One-Year, All-Cause Hospitalization2,3

  • Increased Overall Quality of Life4

For Providers

  • Increased Awareness of Patient Needs

  • Improved Impact on Quality of Care and Health Outcomes

  • Decreased Burden of Capturing Hard-to-Document HF Data

For Health Plans

  • $21,800 One-Year Cost Savings Per Patient2,5

  • $17,500 Cost Savings Per Initial Diagnostic Visit2,5

  • Increased Emphasis on Equitable, Patient-Centric Care

What Surveyed Patients Said

0%
Easy for their clinician to perform during their assessment.
0%
Would take the Vivio test at home as part of their yearly checkup.
0%
Would recommend the Vivio test to friends or family with heart failure symptoms.

Expert Perspectives

“Caring for our senior patients is at the heart of our mission. Because our clinics serve a broad geographic region, bringing the Vivio system directly into our primary care settings allows us to diagnose Heart Failure before patients are expressing symptoms and take action to support treatment without delay. Using Vivio is fast and easy, and having the KCCQ built-in ensures we capture the patient’s symptoms more objectively and consistently.”

Wendy Rissinger, MD, Family Practice Center, Herndon PA

“Our data identified a patient at high risk for heart failure at Dr. DiGennaro’s practice and suggested in-office testing. The resulting positive diagnosis prompted conversations in which the patient revealed previously undisclosed leg swelling. Armed with more and better information, Dr. DiGennaro was able to direct the patient to appropriate medication therapy. Within a month, the patient reported that the leg swelling had resolved, and she was feeling better than she had in a long time.”

Dr. Karthik Rao, Chief Medical Officer, agilon health

“Since adopting the Vivio System in March 2024, we’ve been able to identify changes in heart function earlier and initiate treatment sooner. It has become a valued part of our primary care strategy and allows us to have a more engaging connection with our patients while putting the focus on total-person care. Our patients and primary care physicians appreciate the proactive approach.”

Leah Dixson, PA-C, Desert Oasis Healthcare, Palm Springs CA

“We are proud of the role our technology is playing in practices across the country to make early heart failure diagnosis more accessible, leading to improved patient outcomes and greater clinician satisfaction. Through earlier disease identification, we are helping the healthcare system better control the high and growing costs of heart failure.”

Dr. Thomas Cheek, Chief Medical Officer, Ventric Health

Enterprise-ready security and compliance.

Ventric Health is built to meet the security, privacy, and operational expectations of modern healthcare organizations. The Vivio platform supports secure handling of protected health information, integrates safely with EHR systems, and follows industry-recognized security and risk management frameworks.

  • Independently audited infrastructure aligned to SOC 2 controls
  • Secure handling of PHI consistent with HIPAA requirements
  • Security practices informed by the NIST risk assessment framework
  • Healthcare-specific control alignment with HITRUST
  • Information security and risk processes aligned with ISO standards

To learn more about our security, compliance and enterprise readiness, and how it can deliver faster IT approval, reduced vendor risk, and smoother implementation, contact us.

RESOURCES HUB

BLOG

FAQs